5 Projected GLP-1 Trends in 2025 - GoodRx
3 days ago · Fly View Productions/E+ via Getty Images. Originally developed for Type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the weight-loss medication market.And in recent years, their popularity has soared due to their effectiveness and versatility.. As we look ahead into 2025, several key trends are …
Some GLP-1s Achieve More Weight Loss Than Others: Study
WEDNESDAY, Jan. 8, 2025 -- Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been approved for that purpose. A new evidence review published in the Annals of Internal Medicine shows that the widely-known drugs tirzepatide ( Zepbound ) and semaglutide ( Wegovy ) are both safe and ...
Weight loss drugs like Ozempic, Wegovy shrink America's …
Jan 1, 2025 · Losing weight in the new year won't take the same shape as it did in the past. Why it matters: The emergence of groundbreaking new weight-loss drugs is transforming how Americans shed pounds. Nearly 18 million Americans are expected to be taking versions of GLP-1 drugs by 2029, according to investment bank UBS. By the numbers: The drugs — which are currently administered in the form of ...
GLP-1 nonresponders: Up to 1 in 5 people don't lose weight | AP …
Nov 23, 2024 · In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of …
GLP-1 pills are coming, and they could revolutionize weight-loss …
Sep 17, 2024 · The new crop of GLP-1 weight loss drugs all come in the form of injections. New pill versions are in trials now.
GLP-1 drugs for weight loss: Do they lead to muscle mass loss?
Nov 27, 2024 · The development of glucagon-like peptide-1 (GLP-1) drugs, such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
On Sunday, Lilly released new data about retatrutide, an injectable drug that combines GLP-1 and glucagon, plus another hormone called GIP. GIP is thought to improve how the body breaks down...
New GLP-1 weight loss drug Zepbound approved by FDA: What …
Nov 14, 2023 · The FDA recently approved a new Eli Lilly drug, Zepbound (tirzepatide), for chronic weight management in adults with at least one weight-related health condition.
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with …
Jun 23, 2023 · Data are needed regarding the efficacy and safety of the nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron as a once-daily oral therapy for weight reduction in adults with...
After GLP-1, what’s next for weight loss? - Nature
Jun 6, 2023 · The GLP-1 agonist Wegovy has re-energized the hunt for obesity treatments. Alternatives — ranging from bitter taste compounds to lean muscle boosters and bacteria — are already in the...
- Some results have been removed